4DFF image
Deposition Date 2012-01-23
Release Date 2012-03-14
Last Version Date 2024-10-30
Entry Detail
PDB ID:
4DFF
Keywords:
HYDROLASE/HYDROLASE INHIBITOR
Title:
The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Spodoptera frugiperda
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.11 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.19
Space Group:
P 21 21 21
4DFF validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Gene (Uniprot):PDE10A
Chain IDs:A, B
Chain Length:352
Number of Molecules:2
Biological Source:Homo sapiens
UniProt ID:Q9Y233 EC:3.1.4.17
Ligand Molecules
0JP
MG
ZN
Primary Citation
The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia.
Bioorg.Med.Chem.Lett. 22 2585 2589 (2012)
PMID: 22377514 DOI: 10.1016/j.bmcl.2012.01.113

Abstact

The identification of potent and orally active dihydroimidazoisoquinolines as PDE 10A inhibitors is reported. The SAR development led to the discovery of compound 35 as a potent, selective, and orally active PDE10A inhibitor. Compound 35 inhibited MK-801-induced hyperactivity at 3mg/kg and displayed a 10-fold separation between the minimal effective doses for inhibition of MK-801-induced hyperactivity and hypolocomotion in rats.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
4DFF